- Home
- SUPN vs PLMR Comparison
SUPN vs PLMR Comparison
Compare SUPN & PLMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- PLMR
- Stock Information
- Founded
- SUPN 2005
- PLMR 2013
- Country
- SUPN United States
- PLMR United States
- Employees
- SUPN N/A
- PLMR N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- PLMR Property-Casualty Insurers
- Sector
- SUPN Health Care
- PLMR Finance
- Exchange
- SUPN Nasdaq
- PLMR Nasdaq
- Market Cap
- SUPN 2.6B
- PLMR 3.0B
- IPO Year
- SUPN 2012
- PLMR 2019
- Fundamental
- Price
- SUPN $46.02
- PLMR $128.06
- Analyst Decision
- SUPN Strong Buy
- PLMR Buy
- Analyst Count
- SUPN 4
- PLMR 8
- Target Price
- SUPN $63.25
- PLMR $148.57
- AVG Volume (30 Days)
- SUPN 1.0M
- PLMR 248.7K
- Earning Date
- SUPN 11-04-2025
- PLMR 11-06-2025
- Dividend Yield
- SUPN N/A
- PLMR N/A
- EPS Growth
- SUPN N/A
- PLMR 51.73
- EPS
- SUPN N/A
- PLMR 6.40
- Revenue
- SUPN $681,539,000.00
- PLMR $778,362,000.00
- Revenue This Year
- SUPN $8.29
- PLMR $255.68
- Revenue Next Year
- SUPN $22.72
- PLMR $19.34
- P/E Ratio
- SUPN N/A
- PLMR $20.00
- Revenue Growth
- SUPN 4.54
- PLMR 54.59
- 52 Week Low
- SUPN $29.16
- PLMR $94.45
- 52 Week High
- SUPN $57.65
- PLMR $175.85
- Technical
- Relative Strength Index (RSI)
- SUPN 37.29
- PLMR 71.52
- Support Level
- SUPN $43.11
- PLMR $115.24
- Resistance Level
- SUPN $57.34
- PLMR $115.12
- Average True Range (ATR)
- SUPN 2.50
- PLMR 3.38
- MACD
- SUPN -0.98
- PLMR 1.38
- Stochastic Oscillator
- SUPN 19.60
- PLMR 90.51
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About PLMR Palomar Holdings Inc. Common stock
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.